Seems like ACTC was in this position a few years ago. It will be interesting to find out how far they've gotten. I wonder if they just followed the blue print in the journal article that ACTC published?
It should be easily reproducible.
Sometimes, news like this is less than it seems. Sometimes not. Hard to tell.
But ACTC's been working with HG cells for a while longer than the UK's project. I would expect that the brits are reverse engineering it.